Concepedia

Rayhaneh Afjei

RA

Statistics

Publications

10

Citations

851

H-Index

10

Active since

2017

Affiliations

Stanford University(Current)

Stanford Medicine

Rayhaneh Afjei is an author at Stanford University specializing in oncology, chemotherapy, and cancer nanomedicine.

ORCID

Publications per year

2017–2022

10

Publications

10

Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide

Uday Kumar Sukumar, Rajendran JC Bose, Meenakshi Malhotra et al. · Biomaterials · 2019 · 251 citations · Full text

, , +16

Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents

Rajendran JC Bose, Uday Kumar Sukumar, Yitian Zeng et al. · ACS Nano · 2018 · 226 citations

, , +17

Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle

Uday Kumar Sukumar, Rayhaneh Afjei, Katherine W. Ferrara et al. · ACS Nano · 2021 · 94 citations · Full text

, , +17

Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide <i>in vitro</i> and in a mouse model

Meenakshi Malhotra, Thillai Veerapazham Sekar, Jeyarama S. Ananta et al. · Oncotarget · 2018 · 70 citations · Full text

, , +17

Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo

Jennifer Wischhusen, Sayan Mullick Chowdhury, Taehwa Lee et al. · Journal of Controlled Release · 2020 · 66 citations · Full text

, , +14

1–5 of 10